| Literature DB >> 28479296 |
Caitlyn E Bowman1, Susana Rodriguez2, Ebru S Selen Alpergin1, Michelle G Acoba3, Liang Zhao4, Thomas Hartung5, Steven M Claypool3, Paul A Watkins6, Michael J Wolfgang7.
Abstract
Malonyl-coenzyme A (malonyl-CoA) is a central metabolite in mammalian fatty acid biochemistry generated and utilized in the cytoplasm; however, little is known about noncanonical organelle-specific malonyl-CoA metabolism. Intramitochondrial malonyl-CoA is generated by a malonyl-CoA synthetase, ACSF3, which produces malonyl-CoA from malonate, an endogenous competitive inhibitor of succinate dehydrogenase. To determine the metabolic requirement for mitochondrial malonyl-CoA, ACSF3 knockout (KO) cells were generated by CRISPR/Cas-mediated genome editing. ACSF3 KO cells exhibited elevated malonate and impaired mitochondrial metabolism. Unbiased and targeted metabolomics analysis of KO and control cells in the presence or absence of exogenous malonate revealed metabolic changes dependent on either malonate or malonyl-CoA. While ACSF3 was required for the metabolism and therefore detoxification of malonate, ACSF3-derived malonyl-CoA was specifically required for lysine malonylation of mitochondrial proteins. Together, these data describe an essential role for ACSF3 in dictating the metabolic fate of mitochondrial malonate and malonyl-CoA in mammalian metabolism.Entities:
Keywords: ACSF3; CRISPR/Cas; SIRT5; acetyl-CoA; malonate; malonyl-CoA synthetase; malonylation; metabolomics; mitochondrial metabolism; succinylation
Mesh:
Substances:
Year: 2017 PMID: 28479296 PMCID: PMC5482780 DOI: 10.1016/j.chembiol.2017.04.009
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116